Evidence map›Paper›PMID 32987733›Full record

ArticleInternational journal of molecular sciences2020

Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.

Yishay Weill, Ari Zimran, David Zadok, Lauren M Wasser, Shoshana Revel-Vilk, Joel Hanhart, Tama Dinur, David Arkadir, Michal Becker-Cohen

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Retinal thinning in phenylketonuria and Gaucher disease type 3.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yishay WeillDepartment of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.ORCID 0000-0003-4714-2594
Ari ZimranFaculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel.ORCID 0000-0003-0077-8608
David ZadokDepartment of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Lauren M WasserDepartment of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Shoshana Revel-VilkFaculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel.ORCID 0000-0001-9151-0337
Joel HanhartDepartment of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Tama DinurFaculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel.
David ArkadirFaculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel.
Michal Becker-CohenFaculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1 individuals and 30 healthy volunteers between the ages 40-75 years were prospectively enrolled. Macular and optic nerve optical coherence tomography (OCT) scans of both eyes of each patient were performed and thickness maps were compared between groups. Patients with a known neurodegenerative disease, glaucoma, high myopia and previous intraocular surgeries were excluded. It was shown that patients with GD1 presented with higher incidence of abnormal pRNFL OCT scan and showed significantly thinner areas of pRNFL and macular ganglion cell complex (GCC) when compared to a healthy control population. Changes in retinal thickness were not associated with GD1 genotype, treatment status, disease monitoring biomarker (lyso-Gb1) and severity score index (Zimran SSI). Further investigations are needed to determine whether these findings possess functional visual implications and if retinal thinning may serve as biomarker for the development of future neurodegenerative disease in this population.

Indexed as

AdultAgedCase-Control StudiesFemaleGaucher DiseaseHumansMaleMiddle AgedNerve FibersOptic NerveProspective StudiesRetinal Ganglion CellsVisual Acuityganglion cell complexGaucher diseaseneurodegenerative disorderoptical coherence tomographyretinal ganglion cellsretinal nerve fiber layerretinal thinning

Identifiers

PMID32987733
PMCPMC7582605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.